Indexed by Science Citation Index (SciSearch), International Pharmaceutical Abstract, Chemical Abstracts, Embase, Index Copernicus, EBSCO, African Index Medicus, JournalSeek, Journal Citation Reports/Science Edition, Directory of Open Access Journals (DOAJ), African Journal Online, Bioline International, Open-J-Gate

ISSN: 1596-5996 (print); 1596-9827 (electronic)-


Home | Back Issues | Current Issue | Review manuscript | Submit manuscript

 
 

This Article

 

Abstract

 

Full-Text (PDF)

 

Table of contents

 

Comments

 

Letters

 

Comments to Editor

 

e-mail Alert

 

Sign Up

 

Original Research Article


Formulation of Thermosensitive Hydrogel Containing Cyclodextrin for Controlled Drug Delivery of Camptothecin

Swatantra Kumar Singh Kushwaha1*, Awani Kumar Rai1 and Satyawan Singh2

1Pranveer Singh Institute of Technology, Kanpur, 2Saroj Institute of Technology & Management, Lucknow, India

 

*For correspondence: Email: swatantrakushwaha@yahoo.co.in; Tel: +91-9450560321

 

Received: 30 August 2013                                                                     Revised accepted: 1 May 2014

 

Tropical Journal of Pharmaceutical Research, July 2014; 13(7): 1007-1012

http://dx.doi.org/10.4314/tjpr.v13i7.1   

Abstract

 

Purpose: To formulate and evaluate temperature-sensitive, controlled-release camptothecin hydrogel for anticancer drug delivery.

Method: Temperature-sensitive hydrogel based on chitosan/β-glycerophosphate (β-GP)/β-cyclodextrin (β-CD) was prepared by crosslinking method. The formulations were characterized by Fourier transform infrared spectroscopy (FTIR), x-ray diffraction (XRD), gelation time, and viscometry, as well as for controlled release. The formulation, containing camptothecin, was studied by MTT assay on tumor cell MCF-7. The effectiveness of treatment was measured in terms of controlled tumor growth inhibition (TGI).

Results: The hydrogel formulation showed good properties in terms of pH, gelation, viscosity and in-vitro release. The gelation temperature and viscosity of the formulation was optimum. Camptothecin (CPT) released from the hydrogel (TF8) over 8 h in pH 7.4 buffer ranged from 38.97 - 92.5 %, and varied according to the composition of the hydrogels. Release of camptothecin was lowest from preparations without cyclodextrins. Tumor growth inhibition activity of CPT in MCF-7 cell was highest for the formulation containing 1 % chitosan, 8 % β-GP and 1 % β-CD while no inhibition was observed for the blank temperature sensitive hydrogel formulation.

Conclusion: These formulations are a promising and more effective delivery system that can be developed to serve as an alternative to the conventional system for anticancer drug delivery.

 

Keywords: Hydrogel, Chitosan, β-Glycerophosphate, β-Cyclodextrin, Camptothecin, MCF-7 cell line

Copyright@2002-2010. Pharmacotherapy Group, Faculty of Pharmacy, University of Benin, Benin City. All rights reserved.

Powered by Poracom E-mail: jmanager@poracom.net